EUVIMEDObjevte EUVIMED
Crossref

Mitochondrial Fission, Fusion, and Mitophagy in Liver Fibrosis, Cirrhosis, and Hepatocellular Carcinoma

Xiaoling Zhou, Jialing Liu, Qionghui Huang, Baihan Liu, Yanmei Lan, Faming Shu, Zhuchun Jiang, Ding Zhang

Journal of Visualized Experiments · 2026-11-10 · (237)

DOI: 10.3791/75227 ↗

At a glance

Journal article in Journal of Visualized Experiments, published online on 2026-11-10. Written by Xiaoling Zhou and 7 co-authors.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Mitochondrial fission, fusion, and mitophagy regulate cellular responses to chronic liver injury and the metabolic demands of fibrogenic and malignant cells. This review examines these processes in liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC), with emphasis on the experimental conditions that determine their effects. In hepatic stellate cells (HSCs), PINK1-associated mitochondrial quality control can restrain activation during oxidative or lipotoxic stress, whereas AMP-activated protein kinase (AMPK)-dependent mitochondrial turnover contributes to the metabolic reprogramming that accompanies HSC activation. Hepatocyte studies connect mitochondrial network maintenance, phospholipid transfer, and selective protein degradation to tissue injury. Human advanced-fibrosis and cirrhosis studies identify etiology-dependent pathway expression and altered respiration in patient-derived models. Experiments in established cirrhotic rats connect mitochondrial antioxidant treatment with portal hemodynamics. In HCC models, fission supports tumor-initiating capacity, and MFN1-associated fusion reduces metastatic behavior. PINK1-associated and FUNDC1-associated mitophagy produce different responses to kinase inhibitors in defined models. The review describes measurements of mitochondrial morphology, DRP1 phosphorylation, lysosomal mitochondrial delivery, mitochondrial DNA localization, and respiratory function. These measurements connect molecular perturbations with cell phenotype and organ-level outcomes. The evidence supports selecting mitochondrial interventions according to the affected cell population, the mechanism demonstrated in that model, and the relevant tissue or treatment outcome.

Cite

APA

Zhou, X., Liu, J., Huang, Q., Liu, B., Lan, Y., Shu, F., Jiang, Z., & Zhang, D. (2026). Mitochondrial Fission, Fusion, and Mitophagy in Liver Fibrosis, Cirrhosis, and Hepatocellular Carcinoma. Journal of Visualized Experiments. https://doi.org/10.3791/75227

Vancouver

Zhou X, Liu J, Huang Q, Liu B, Lan Y, Shu F, et al. Mitochondrial Fission, Fusion, and Mitophagy in Liver Fibrosis, Cirrhosis, and Hepatocellular Carcinoma. Journal of Visualized Experiments. 2026. doi:10.3791/75227

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiaoling and Liu, Jialing and Huang, Qionghui and Liu, Baihan and Lan, Yanmei and Shu, Faming and Jiang, Zhuchun and Zhang, Ding},
  title = {Mitochondrial Fission, Fusion, and Mitophagy in Liver Fibrosis, Cirrhosis, and Hepatocellular Carcinoma},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {237},
  doi = {10.3791/75227}
}
Start for free →